{"gene":"ADAMTS4","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2000,"finding":"ADAMTS-4 cleaves aggrecan at the Glu373-Ala374 bond (IGD) and at four additional sites within the chondroitin sulfate-rich region (Glu1480-Gly1481, Glu1667-Gly1668, Glu1771-Ala1772, Glu1871-Leu1872), with CS-rich region cleavage being more efficient than IGD cleavage.","method":"In vitro cleavage assay with recombinant human ADAMTS-4 and native aggrecan; N-terminal sequencing of fragments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic assay with N-terminal sequencing, site-specific identification","pmids":["10751421"],"is_preprint":false},{"year":2000,"finding":"The thrombospondin type-1 (TSP-1) motif of ADAMTS-4 binds to glycosaminoglycans of aggrecan and is required for substrate recognition and cleavage; truncation lacking TSP-1 abolishes aggrecanase activity, and GAG-free aggrecan is not cleaved.","method":"Truncation mutant activity assays, peptide competition binding assays, cleavage assays with GAG-free aggrecan","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (truncation mutants, peptide competition, substrate modification) in a single study","pmids":["10827174"],"is_preprint":false},{"year":2000,"finding":"ADAMTS-4 cleaves brevican at the Glu395-Ser396 bond within the central non-homologous domain, a site distinct from the Ala360-Phe361 bond cleaved by MMPs.","method":"In vitro cleavage assay with recombinant ADAMTS-4 and brevican; NH2-terminal sequence analysis of fragments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with N-terminal sequencing confirming cleavage site","pmids":["10986281"],"is_preprint":false},{"year":2001,"finding":"TIMP-3 N-terminal inhibitory domain is a potent inhibitor of ADAMTS-4 with Ki values in the subnanomolar range, making it the first identified endogenous inhibitor of aggrecanases.","method":"In vitro inhibition assay using truncated N-TIMP-3 expressed in bacteria against recombinant ADAMTS-4 and ADAMTS-5","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro inhibition kinetics with purified recombinant proteins","pmids":["11278243"],"is_preprint":false},{"year":2001,"finding":"ADAMTS-4 cleaves versican V1 at the Glu441-Ala442 bond, generating a DPEAAE neoepitope, and mature ADAMTS-4 was detected in human aortic intima.","method":"In vitro cleavage of recombinant versican substrate and native human versican; neoepitope antiserum detection; Western analysis of aortic extracts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic assay with site identification and in vivo correlation","pmids":["11278559"],"is_preprint":false},{"year":2002,"finding":"ADAMTS-4 activation requires two sequential steps: (1) prodomain removal by a furin-like activity generating the p75 form, and (2) MMP-mediated C-terminal truncation generating p60/p50 forms; only the C-terminally truncated forms exhibit aggrecanase activity.","method":"Stable transfection of human chondrosarcoma cells; Western analysis with domain-specific antisera; furin and MMP inhibitor treatments; preparative SDS-PAGE isolation and activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple inhibitor approaches with direct activity assays on isolated forms","pmids":["11796708"],"is_preprint":false},{"year":2002,"finding":"Full-length ADAMTS-4 undergoes autocatalytic C-terminal truncation to generate ~53 kDa and ~40 kDa isoforms with reduced affinity for sulfated GAGs; multiple GAG-binding sites are present in the cysteine-rich and spacer domains in addition to the TSP-1 motif.","method":"C-terminal sequencing and mass analysis of autocleaved products; binding competition with native and deglycosylated aggrecan; synthetic peptide competition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical characterization with multiple orthogonal approaches","pmids":["12202483"],"is_preprint":false},{"year":2002,"finding":"ADAMTS-4 cleaves at the Glu373-Ala374 aggrecanase site primarily, and secondarily cleaves at the Asn341-Phe342 MMP site; TIMP-3 (but not TIMP-1 or TIMP-2) inhibits both cleavages, confirming they are genuine ADAMTS-4 activities.","method":"In vitro cleavage of native and recombinant aggrecan; inhibitor studies with TIMP-3, TIMP-1, TIMP-2; cleavage site mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — site-directed mutagenesis of cleavage sites combined with selective TIMP inhibition","pmids":["11854269"],"is_preprint":false},{"year":2003,"finding":"The non-catalytic C-terminal spacer domain of ADAMTS-4 masks general proteolytic activity; deletion of the spacer domain broadens substrate specificity (enabling cleavage of Glu373-Ala374, Cm-Tf, fibromodulin, decorin), while the thrombospondin type I domain is critical for aggrecanase activity; full-length ADAMTS-4 binds pericellular/extracellular matrix via its spacer domain.","method":"Domain deletion mutant expression in mammalian cells; aggrecan-degrading and general proteolytic activity assays; matrix binding studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic domain deletion mutagenesis with multiple substrate assays","pmids":["14662755"],"is_preprint":false},{"year":2003,"finding":"IL-1 induces aggrecanase activity in chondrocytes by activating a constitutively produced pool of ADAMTS-4 (not by increasing protein abundance); IL-1-mediated activation involves an activator that can be blocked by heparin or chondroitinase ABC treatment.","method":"Western blot of cell lysates and cartilage; immunofluorescence; aggrecanase activity assay on peptide substrate; heparin and chondroitinase treatment","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods in single lab study","pmids":["12528112"],"is_preprint":false},{"year":2003,"finding":"ADAMTS-4 activation on the cell surface involves C-terminal cleavage of the p68 form to the p53 form mediated by GPI-anchored MT4-MMP (MMP-17); the activated p53 form associates with syndecan-1 through both chondroitin sulfate and heparan sulfate chains.","method":"Co-transfection with active/inactive MT4-MMP mutants; phosphatidylinositol-specific phospholipase C treatment; glycosaminoglycan lyase digestions; fluorescence-assisted carbohydrate electrophoresis; immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal approaches including active-site mutant controls and specific glycosaminoglycan characterization","pmids":["14701864"],"is_preprint":false},{"year":2004,"finding":"Furin cleaves pro-ADAMTS-4 at RPRR/RAKR/KR sites in the trans-Golgi network to remove the prodomain; pro-ADAMTS-4 co-precipitates with furin (but mature form does not), indicating physical interaction of furin with the prodomain.","method":"Furin-specific inhibitor treatment; RNA interference of furin; brefeldin A treatment; co-localization by immunofluorescence; co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple approaches including RNAi, inhibitors, co-IP, and subcellular localization","pmids":["14744861"],"is_preprint":false},{"year":2004,"finding":"ADAMTS-4 binds to the C-terminal domain of fibronectin via its spacer domain; this interaction inhibits aggrecanase activity with IC50 of ~110 nM; ADAMTS-4 co-localizes with fibronectin on the cell surface.","method":"Yeast two-hybrid screening; chemical cross-linking; solid-phase binding assay; confocal microscopy; aggrecanase activity inhibition assay with fibronectin and fragments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — yeast two-hybrid plus multiple biochemical validations plus functional inhibition assay","pmids":["15161923"],"is_preprint":false},{"year":2004,"finding":"ADAMTS-4 cleaves brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein (GHAP); multiple ADAMTS-4 protein forms are present in human cerebellum extracts.","method":"Neoepitope antiserum identification; in vitro digestion of human cerebellum proteoglycans with ADAMTS-4; Western analysis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic cleavage with neoepitope identification","pmids":["14561220"],"is_preprint":false},{"year":2005,"finding":"N-terminal activation of ADAMTS-4 is mediated by proprotein convertases furin, PACE4, and PC5/6 (cleaving at Arg212/Phe213), and also by MMP-9 and trypsin; autocatalytic prodomain removal does not occur under standard conditions but can occur at basic pH (8-10).","method":"In vitro activation assays with various proteinases across pH ranges, ionic strengths, and temperatures; prodomain removal and activity measurement","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 — comprehensive in vitro reconstitution with multiple conditions","pmids":["16289022"],"is_preprint":false},{"year":2007,"finding":"TIMP-3 inhibition of full-length ADAMTS-4 is enhanced in the presence of aggrecan through binding of chondroitin 6-sulfate glycosaminoglycans to the TSP-1 and spacer domains of ADAMTS-4, forming a complex with improved TIMP-3 binding affinity.","method":"FRET peptide assay; binding competition experiments with native and deglycosylated aggrecan; specific glycosaminoglycan competition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative kinetic assay plus substrate competition experiments","pmids":["17470431"],"is_preprint":false},{"year":2007,"finding":"Non-catalytic ancillary domains of ADAMTS-4 regulate extracellular matrix localization (spacer domain is critical) and proteolytic activity; the spacer domain is required for matrix retention, while sequential inclusion of C-terminal domains enhances activity against multiple substrates.","method":"Domain deletion mutant expression; ECM interaction studies; activity assays against aggrecan, Cm-Tf, fibromodulin, decorin, biglycan, fibronectin","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic domain deletion with multiple substrate assays, comparative with ADAMTS-5","pmids":["17430884"],"is_preprint":false},{"year":2007,"finding":"Crystal structures of ADAMTS-4 (in apo and inhibitor-bound forms) reveal two catalytic-site configurations: an autoinhibited closed form and an open binding form, suggesting the enzyme exists as an ensemble of isomers with only the open form being proteolytically active.","method":"X-ray crystallography of human ADAMTS-4 in apo and inhibitor-bound forms","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with structural functional interpretation","pmids":["18042673"],"is_preprint":false},{"year":2007,"finding":"ADAMTS-4 aggrecan cleavage operates through an exosite mechanism: substrate initially binds at an exosite (reflected by apparent Km), followed by active-site binding; active-site inhibitors show noncompetitive kinetics with aggrecan but competitive kinetics with peptide substrates, consistent with this two-step model.","method":"Inhibition kinetics with hydroxamic acid SC81956 using varying aggrecan and peptide substrate concentrations; fluorogenic peptide assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — rigorous kinetic analysis with multiple substrate types revealing mechanistic model","pmids":["17487981"],"is_preprint":false},{"year":2009,"finding":"ADAMTS-4 cleaves hevin (SPARC-like 1) in the mouse cerebellum; this proteolysis is important for normal cerebellar development; ADAMTS-4 co-localizes with hevin-derived SPARC-like fragments in vivo.","method":"In vitro digestion of hevin by ADAMTS-4; comparison of brain lysate fragments with in vitro cleavage products; co-localization by monoclonal antibody; developmental analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro cleavage corroborated by in vivo co-localization","pmids":["20018883"],"is_preprint":false},{"year":2010,"finding":"N-TIMP-3 reactive-site mutants with additional N-terminal alanine residues selectively inhibit ADAMTS-4 and ADAMTS-5 over MMPs; these mutants inhibit aggrecan but not collagen degradation in cartilage explants; molecular modelling indicates unique stabilizing contacts with the catalytic domains.","method":"In vitro inhibition assays with recombinant proteins; cartilage explant aggrecan/collagen degradation assays; molecular modelling","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — recombinant protein inhibition kinetics combined with tissue-level functional validation","pmids":["20645923"],"is_preprint":false},{"year":2012,"finding":"ADAMTS-4 is endocytosed via LRP1 on chondrocyte cell surface; the cysteine-rich and spacer domains mediate LRP1 binding; ADAMTS-4 binds LRP1 clusters II and IV with KD ~98 and 73 nM respectively; half-life of endocytosis ~220 min; ADAMTS-5 competitively inhibits ADAMTS-4 endocytosis due to higher LRP1 affinity.","method":"Domain deletion mutagenesis; soluble LRP1 ligand binding cluster binding assays; endocytosis rate measurements; competitive inhibition experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — quantitative binding measurements with domain mapping and competitive inhibition","pmids":["24474687"],"is_preprint":false},{"year":2012,"finding":"ADAMTS-4 degrades chondroitin sulfate proteoglycan core proteins (brevican, neurocan, phosphacan) and reverses their inhibition of neurite outgrowth in vitro; local administration of ADAMTS-4 promotes motor function recovery and axonal regeneration/sprouting after spinal cord contusion injury in mice.","method":"In vitro proteoglycan cleavage assay; in vitro neurite growth assay; in vivo spinal cord contusion model with local ADAMTS-4 administration; motor function assessment","journal":"Journal of neuroinflammation","confidence":"High","confidence_rationale":"Tier 2 — direct in vitro enzyme activity correlated with in vivo functional recovery","pmids":["22420304"],"is_preprint":false},{"year":2013,"finding":"TNF-α and IL-1β regulate ADAMTS-4 expression in nucleus pulposus cells through MAPK (ERK1, p38α, p38β2, p38γ) and NF-κB (p65, IKK-α, IKK-β) signaling; p65 activates the ADAMTS4 promoter while p50 blocks this; lentiviral shRNA knockdown of pathway components reduces ADAMTS-4 and aggrecan degradation.","method":"Real-time RT-PCR; Western blotting; transient transfections with promoter constructs; gain/loss-of-function with dominant negative constructs; lentiviral shRNA knockdown; MAPK/NF-κB inhibitor studies","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including promoter assays, genetic knockdown, and pharmacological inhibition","pmids":["23602832"],"is_preprint":false},{"year":2015,"finding":"CCN1 (Cyr61) binds specifically to the cysteine-rich domain of ADAMTS-4 and inhibits its aggrecanase activity; TGF-β upregulates CCN1 which suppresses ADAMTS-4 activity even when ADAMTS-4 protein is induced, while IL-1α downregulates CCN1 allowing ADAMTS-4 activity.","method":"Co-purification and mass spectrometry identification; immunoprecipitation; solid-phase binding assay; aggrecan digestion assay; domain deletion mapping; siRNA knockdown of CCN1","journal":"Arthritis & rheumatology","confidence":"High","confidence_rationale":"Tier 1-2 — proteomics-based identification followed by multiple biochemical validations and functional inhibition assay","pmids":["25709087"],"is_preprint":false},{"year":2017,"finding":"ADAMTS-4 translocates to the nucleus in smooth muscle cells under stress conditions and directly cleaves/degrades poly ADP ribose polymerase-1 (PARP-1), leading to SMC apoptosis; ADAMTS-4 deficiency reduces aortic aneurysm formation, versican degradation, and macrophage infiltration in mice.","method":"Mouse knockout model (Adamts4-/-); immunofluorescence for nuclear translocation; in vitro PARP-1 cleavage assay; aortic diameter measurement; histological analysis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro PARP-1 cleavage assay plus in vivo knockout with multiple phenotypic readouts","pmids":["28955046"],"is_preprint":false},{"year":2018,"finding":"ADAMTS-4 generates N-truncated Aβ4-x peptides by cleaving at a recognition site within the amyloid-β sequence; inducible overexpression increases Aβ4-40 secretion without altering Aβ1-x levels; ADAMTS4 knockout reduces Aβ4-40 levels in 5xFAD mice; ADAMTS-4 is exclusively expressed in oligodendrocytes in adult mouse brain.","method":"Inducible HEK293 overexpression; ADAMTS4 knockout mouse on 5xFAD background; cultured oligodendrocytes from ADAMTS4-/- mice; Aβ peptide measurement by ELISA/immunoassay","journal":"Acta neuropathologica","confidence":"High","confidence_rationale":"Tier 1-2 — overexpression and knockout approaches with direct substrate cleavage measurement","pmids":["30426203"],"is_preprint":false},{"year":2020,"finding":"ADAMTS-4 produced by damage-responsive lung fibroblasts remodels the ECM during viral infection, promoting robust immune cell infiltration; ADAMTS-4 levels in the lower respiratory tract correlate with severity of influenza infection in humans.","method":"Mouse influenza model; single-cell transcriptomics identifying fibroblast activation states; ADAMTS4 functional studies in lung; human cohort ADAMTS4 measurements","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — single-cell transcriptomics with in vivo functional evidence and human clinical correlation","pmids":["33116313"],"is_preprint":false},{"year":2021,"finding":"ADAMTS-4 cleaves versican V1 at multiple sites beyond the known Glu441-Ala442 bond, with a preference for P1-Glu residues; 21 novel cleavage sites were identified within versican.","method":"Label-free quantitative LC-MS/MS proteomics comparing active vs. catalytically inactive mutant ADAMTS-4 digests of recombinant versican; z-score statistical ranking","journal":"Journal of proteomics","confidence":"High","confidence_rationale":"Tier 1 — quantitative proteomics with catalytically inactive mutant controls","pmids":["34450332"],"is_preprint":false},{"year":2006,"finding":"The human ADAMTS-4 promoter is regulated by transcription factors NFATp and Runx2 (binding sites identified); the NFI site at -441 to -429 acts as a negative regulator in chondrocytes; the region -383 to +10 is required for full promoter activity.","method":"Promoter cloning; deletion variants reporter assays; transfection in porcine chondrocytes and NIH3T3 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assays with deletion mutants in relevant cell types","pmids":["16677612"],"is_preprint":false},{"year":2018,"finding":"Sox4 transcription factor directly binds the ADAMTS-4 promoter and upregulates its expression; Sox4 overexpression induces ADAMTS-4 and ADAMTS-5 expression and causes articular cartilage destruction in organ cultures.","method":"Microarray; luciferase reporter assay; chromatin immunoprecipitation; adenovirus-mediated Sox4 overexpression in mouse femoral head cartilage organ cultures","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP plus reporter assay plus in vivo organ culture functional validation","pmids":["30016600"],"is_preprint":false},{"year":2008,"finding":"Hyaluronan (HA) suppresses IL-1α-induced ADAMTS-4 expression in osteoarthritic chondrocytes through CD44 and ICAM1 signaling pathways, by downregulating IRAK-1 and ERK1/2 phosphorylation via IRAK-M upregulation; HA does not directly inhibit ADAMTS-4 enzymatic activity.","method":"Real-time PCR; Western blotting; immunoblotting for signaling molecules; antibody blocking of CD44/ICAM1; siRNA knockdown of ADAMTS-4","journal":"Annals of the rheumatic diseases","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical approaches identifying signaling intermediates","pmids":["18662930"],"is_preprint":false},{"year":2012,"finding":"ADAMTS-4 and ADAMTS-5 cleave Reelin, with regulation by tPA, TIMPs, α-2-macroglobulin, serpins, and MMP-9; their expression overlaps with Reelin in the murine hippocampus.","method":"In vitro cleavage assays; inhibitor co-incubation studies; immunofluorescence co-localization in brain","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vitro cleavage assay with multiple endogenous modulators tested","pmids":["23082219"],"is_preprint":false},{"year":2011,"finding":"ADAMTS-4 and ADAMTS-1 play redundant and essential roles in perinatal renal medulla development; combined knockout of both leads to lethal renal medulla thinning in >95% of double-null mice, while single knockouts are phenotypically normal.","method":"Gene targeting to create Adamts4-null mice; crossing with Adamts1-null mice; histological analysis of kidneys","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 — double-knockout genetic epistasis with clear developmental phenotype","pmids":["21584905"],"is_preprint":false}],"current_model":"ADAMTS-4 is a secreted zinc metalloproteinase activated by furin-mediated prodomain removal in the trans-Golgi network and subsequent MMP/MT4-MMP-mediated C-terminal spacer domain truncation at the cell surface; it cleaves aggrecan, versican, brevican, and other proteoglycans at Glu-X bonds via an exosite-assisted mechanism requiring GAG binding through its TSP-1, cysteine-rich, and spacer domains; its activity is regulated extracellularly by TIMP-3 (Ki subnanomolar), fibronectin, and CCN1 binding, and its clearance is controlled by LRP1-mediated endocytosis; it also generates N-truncated Aβ4-x amyloid peptides and can translocate to the nucleus to cleave PARP-1 in smooth muscle cells, driving apoptosis."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing ADAMTS-4 as a multi-site aggrecanase and identifying its proteoglycan substrate repertoire resolved the identity of the long-sought 'aggrecanase' activity and revealed that it also cleaves brevican at a distinct site from MMPs.","evidence":"In vitro cleavage of native aggrecan and brevican with recombinant ADAMTS-4, N-terminal sequencing of fragments","pmids":["10751421","10986281"],"confidence":"High","gaps":["Relative contribution of each cleavage site to in vivo cartilage degradation unknown","Kinetic parameters for individual sites not fully determined"]},{"year":2000,"claim":"Demonstrating that the TSP-1 motif binds aggrecan GAGs and is essential for cleavage established the principle that ADAMTS-4 uses non-catalytic domains for substrate recognition, not just catalysis.","evidence":"Truncation mutants, peptide competition, and GAG-free aggrecan cleavage assays","pmids":["10827174"],"confidence":"High","gaps":["Precise structural basis of TSP-1–GAG interaction not resolved","Whether TSP-1 domain is equally required for non-aggrecan substrates unclear"]},{"year":2001,"claim":"Identifying TIMP-3 as the first endogenous inhibitor of ADAMTS-4 with subnanomolar affinity, and showing versican cleavage and aortic presence, defined the enzyme's regulatory framework and expanded its role beyond cartilage.","evidence":"Quantitative in vitro inhibition kinetics; in vitro versican V1 cleavage with neoepitope detection; Western blot of human aortic extracts","pmids":["11278243","11278559"],"confidence":"High","gaps":["In vivo relevance of TIMP-3 regulation in specific tissues not demonstrated","Other potential endogenous inhibitors not yet screened"]},{"year":2002,"claim":"Discovering that ADAMTS-4 activation requires sequential furin-mediated prodomain removal and MMP-mediated C-terminal truncation revealed a two-step zymogen activation pathway controlling enzyme specificity.","evidence":"Stable transfection with domain-specific antisera, furin/MMP inhibitor treatments, and activity assays of isolated enzyme forms; autocatalysis characterization with mass analysis","pmids":["11796708","12202483"],"confidence":"High","gaps":["Identity of the specific MMP(s) responsible in vivo not definitively established at this stage","Relative rates of autocatalysis versus MMP-mediated truncation in physiological settings unknown"]},{"year":2003,"claim":"Identifying MT4-MMP as the cell-surface protease generating the active p53 form and syndecan-1 as a cell-surface docking partner placed ADAMTS-4 activation in a pericellular context, while IL-1 was shown to activate a pre-existing enzyme pool rather than inducing new synthesis.","evidence":"Co-transfection with MT4-MMP mutants, GAG lyase digestions, immunoprecipitation; chondrocyte IL-1 stimulation with heparin/chondroitinase treatment","pmids":["14701864","12528112"],"confidence":"High","gaps":["Whether syndecan-1 association enhances or restricts activity in vivo unknown","Nature of the GAG-sensitive IL-1-induced activator not identified"]},{"year":2003,"claim":"Systematic domain deletion showed that the spacer domain both masks broad proteolytic activity and anchors the enzyme in ECM, revealing a built-in autoinhibitory/localization mechanism.","evidence":"Domain deletion mutants with multiple substrate and matrix binding assays","pmids":["14662755"],"confidence":"High","gaps":["Structural basis of spacer-mediated autoinhibition not resolved","How spacer removal alters substrate selectivity in vivo unknown"]},{"year":2004,"claim":"Mapping furin cleavage to the trans-Golgi network via physical furin–prodomain interaction and identifying fibronectin as an extracellular inhibitor binding the spacer domain defined two distinct compartmental control points for ADAMTS-4 activity.","evidence":"Furin RNAi, brefeldin A treatment, co-IP; yeast two-hybrid, cross-linking, and activity inhibition with fibronectin","pmids":["14744861","15161923"],"confidence":"High","gaps":["Whether fibronectin inhibition is relevant in cartilage ECM context not tested","Contribution of PACE4/PC5-6 versus furin in different tissues not resolved"]},{"year":2007,"claim":"Crystal structures revealing open/closed catalytic-site conformations and kinetic demonstration of an exosite mechanism unified the biochemical observations into a model where substrate first docks at an exosite before engaging the active site.","evidence":"X-ray crystallography of apo and inhibitor-bound forms; inhibition kinetics showing noncompetitive behavior with aggrecan versus competitive with peptides","pmids":["18042673","17487981"],"confidence":"High","gaps":["No co-crystal with a macromolecular substrate to identify the exosite structurally","Whether the open/closed equilibrium is modulated by cofactors in vivo unknown"]},{"year":2007,"claim":"Showing that TIMP-3 inhibition is enhanced by aggrecan-derived chondroitin 6-sulfate binding to the ancillary domains revealed a substrate-assisted inhibition mechanism, linking GAG binding to regulation.","evidence":"FRET kinetic assays with native and deglycosylated aggrecan; specific GAG competition","pmids":["17470431"],"confidence":"High","gaps":["Whether this applies to other substrates or tissue contexts not established","Stoichiometry of the ternary TIMP-3/ADAMTS-4/CS complex not determined"]},{"year":2009,"claim":"Discovery of hevin as a brain substrate and ADAMTS-4's role in cerebellar development expanded its functional scope beyond connective tissue proteoglycan degradation.","evidence":"In vitro hevin cleavage, co-localization of ADAMTS-4 with hevin-derived fragments in mouse cerebellum","pmids":["20018883"],"confidence":"Medium","gaps":["Hevin cleavage site not precisely mapped","No knockout validation of this function in cerebellum"]},{"year":2011,"claim":"Double knockout with ADAMTS-1 revealed redundant essential roles in renal medulla morphogenesis, establishing ADAMTS-4 as a developmental enzyme with tissue-specific requirements masked by paralog compensation.","evidence":"Adamts4−/−;Adamts1−/− double-knockout mice with lethal renal medulla thinning","pmids":["21584905"],"confidence":"High","gaps":["Specific substrate(s) mediating renal development not identified","Whether versican is the relevant renal substrate unknown"]},{"year":2012,"claim":"Demonstrating LRP1-mediated endocytosis via the cysteine-rich/spacer domains and competitive displacement by ADAMTS-5 defined the clearance pathway controlling extracellular ADAMTS-4 levels.","evidence":"Domain deletion binding assays, endocytosis rate measurements, competitive inhibition with ADAMTS-5","pmids":["24474687"],"confidence":"High","gaps":["In vivo validation of LRP1 clearance pathway not performed","Whether LRP1 endocytosis delivers ADAMTS-4 for degradation or recycling unknown"]},{"year":2013,"claim":"Mapping the signaling cascades (MAPK/NF-κB) through which TNF-α and IL-1β induce ADAMTS4 transcription, along with identification of promoter-binding transcription factors (NFATp, Runx2, Sox4), defined the transcriptional regulation of the gene in chondrocytes and intervertebral disc cells.","evidence":"Promoter reporter assays, ChIP, lentiviral shRNA knockdown of pathway components, MAPK/NF-κB inhibitors; adenoviral Sox4 overexpression in organ cultures","pmids":["23602832","16677612","30016600"],"confidence":"High","gaps":["Epigenetic regulation not addressed","Whether these pathways operate identically in cartilage versus vascular tissue unknown"]},{"year":2015,"claim":"Identification of CCN1 as a TGF-β-induced extracellular inhibitor binding the cysteine-rich domain added a third mode of extracellular activity control alongside TIMP-3 and fibronectin.","evidence":"Co-purification/MS identification, immunoprecipitation, domain mapping, siRNA knockdown, aggrecan digestion assay","pmids":["25709087"],"confidence":"High","gaps":["Whether CCN1, fibronectin, and TIMP-3 compete or cooperate in vivo not tested","Structural basis of CCN1 inhibition unknown"]},{"year":2017,"claim":"Discovering nuclear translocation and PARP-1 cleavage in stressed smooth muscle cells, along with knockout protection from aortic aneurysm, revealed an unexpected intracellular pro-apoptotic function beyond its canonical extracellular role.","evidence":"Adamts4−/− mouse aortic aneurysm model; immunofluorescence for nuclear localization; in vitro PARP-1 cleavage assay","pmids":["28955046"],"confidence":"High","gaps":["Mechanism of nuclear import not identified","Whether PARP-1 cleavage is direct in vivo or requires cofactors unknown","Generalizability of nuclear function beyond SMCs not tested"]},{"year":2018,"claim":"Demonstrating that ADAMTS-4 generates Aβ4-x amyloid peptides in oligodendrocytes and that knockout reduces Aβ4-40 in an Alzheimer's model established the enzyme as a novel amyloid-processing protease.","evidence":"Inducible HEK293 overexpression; ADAMTS4 knockout on 5xFAD background; cultured oligodendrocytes; Aβ peptide ELISA","pmids":["30426203"],"confidence":"High","gaps":["Precise cleavage site within APP/Aβ sequence not mapped at single-residue resolution","Contribution to human AD pathology not established"]},{"year":2020,"claim":"Implicating fibroblast-derived ADAMTS-4 in lung ECM remodeling during viral infection, with clinical correlation to influenza severity, extended the enzyme's pathophysiological role to innate immunity.","evidence":"Mouse influenza model with single-cell transcriptomics; human cohort ADAMTS4 measurements","pmids":["33116313"],"confidence":"High","gaps":["Specific lung ECM substrates cleaved during infection not identified","Whether ADAMTS-4 is protective or pathogenic in this context not fully resolved"]},{"year":2021,"claim":"Comprehensive proteomics identified 21 novel cleavage sites in versican V1 confirming broad P1-Glu preference, refining the substrate recognition model.","evidence":"Label-free quantitative LC-MS/MS with catalytically inactive mutant controls","pmids":["34450332"],"confidence":"High","gaps":["Functional significance of individual cleavage sites in vivo unknown","Whether these sites are cleaved in native tissue-associated versican not tested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of exosite-mediated substrate recognition on full-length enzyme, the mechanism of nuclear translocation, the pathophysiological relevance of Aβ4-x generation to Alzheimer's disease, and the specific substrates mediating ADAMTS-4's developmental roles in kidney and cerebellum.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure with macromolecular substrate","Nuclear import mechanism uncharacterized","In vivo contribution to AD amyloid burden in humans unknown","Developmental substrates in kidney and brain not identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4,7,8,13,19,22,25,26,28,32]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2,4,8,22,28]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,6,8,12,16,27]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[8,12,16]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[11]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[10,12]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[0,4,8,16,22,27,28]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[5,11,14]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[22,26]}],"complexes":[],"partners":["TIMP3","LRP1","FN1","CCN1","FURIN","MMP17","SDC1","PARP1"],"other_free_text":[]},"mechanistic_narrative":"ADAMTS4 encodes a secreted zinc metalloproteinase that functions as a major aggrecanase and broad-spectrum proteoglycan-degrading enzyme, cleaving aggrecan, versican, brevican, neurocan, phosphacan, hevin, and Reelin at Glu-X bonds through an exosite-assisted mechanism requiring glycosaminoglycan recognition by its thrombospondin type-1, cysteine-rich, and spacer domains [PMID:10751421, PMID:10827174, PMID:17487981, PMID:22420304]. The enzyme is activated by sequential prodomain removal via furin/PACE4/PC5-6 in the trans-Golgi network followed by C-terminal spacer domain truncation by MT4-MMP or other MMPs at the cell surface, generating active p60/p53 forms with altered substrate specificity and reduced matrix retention [PMID:11796708, PMID:14744861, PMID:14701864, PMID:14662755]. Its activity is regulated extracellularly by TIMP-3 (subnanomolar Ki, enhanced by aggrecan-derived chondroitin sulfate), fibronectin binding to the spacer domain, CCN1 binding to the cysteine-rich domain, and LRP1-mediated endocytic clearance, while transcription is controlled by NF-κB/MAPK signaling downstream of IL-1β/TNF-α and by transcription factors Sox4, NFATp, and Runx2 [PMID:11278243, PMID:17470431, PMID:15161923, PMID:25709087, PMID:24474687, PMID:23602832, PMID:30016600]. Beyond cartilage proteoglycan catabolism, ADAMTS-4 generates N-truncated Aβ4-x amyloid peptides in oligodendrocytes, translocates to the nucleus to cleave PARP-1 and drive smooth muscle cell apoptosis during aortic aneurysm, promotes axonal regeneration by degrading inhibitory CSPGs after spinal cord injury, and remodels lung ECM during viral infection [PMID:30426203, PMID:28955046, PMID:22420304, PMID:33116313]."},"prefetch_data":{"uniprot":{"accession":"O75173","full_name":"A disintegrin and metalloproteinase with thrombospondin motifs 4","aliases":["ADMP-1","Aggrecanase-1"],"length_aa":837,"mass_kda":90.2,"function":"Cleaves aggrecan, a cartilage proteoglycan, at the '392-Glu-|-Ala-393' site and may be involved in its turnover (PubMed:10356395, PubMed:10827174). Also cleaves COMP (PubMed:39672391). May play an important role in the destruction of aggrecan in arthritic diseases. Could be a critical factor in the exacerbation of neurodegeneration in Alzheimer disease","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/O75173/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADAMTS4","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADAMTS4","total_profiled":1310},"omim":[{"mim_id":"605421","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 9; ADAMTS9","url":"https://www.omim.org/entry/605421"},{"mim_id":"605011","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 3; ADAMTS3","url":"https://www.omim.org/entry/605011"},{"mim_id":"605009","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 7; ADAMTS7","url":"https://www.omim.org/entry/605009"},{"mim_id":"605008","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 6; ADAMTS6","url":"https://www.omim.org/entry/605008"},{"mim_id":"605007","title":"A DISINTEGRIN-LIKE AND METALLOPROTEINASE WITH THROMBOSPONDIN TYPE 1 MOTIF, 5; ADAMTS5","url":"https://www.omim.org/entry/605007"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":108.5},{"tissue":"ovary","ntpm":84.8}],"url":"https://www.proteinatlas.org/search/ADAMTS4"},"hgnc":{"alias_symbol":["KIAA0688","ADAMTS-2","ADMP-1"],"prev_symbol":[]},"alphafold":{"accession":"O75173","domains":[{"cath_id":"3.40.390.10","chopping":"215-419","consensus_level":"high","plddt":89.4455,"start":215,"end":419},{"cath_id":"3.40.1620.60","chopping":"440-516","consensus_level":"high","plddt":89.736,"start":440,"end":516},{"cath_id":"-","chopping":"583-640","consensus_level":"medium","plddt":85.5107,"start":583,"end":640},{"cath_id":"2.60.120.830","chopping":"686-804","consensus_level":"high","plddt":90.7829,"start":686,"end":804},{"cath_id":"2.40.128","chopping":"60-166_177-183","consensus_level":"high","plddt":67.7167,"start":60,"end":183}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75173","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75173-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75173-F1-predicted_aligned_error_v6.png","plddt_mean":80.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADAMTS4","jax_strain_url":"https://www.jax.org/strain/search?query=ADAMTS4"},"sequence":{"accession":"O75173","fasta_url":"https://rest.uniprot.org/uniprotkb/O75173.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75173/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75173"}},"corpus_meta":[{"pmid":"11278243","id":"PMC_11278243","title":"TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278243","citation_count":400,"is_preprint":false},{"pmid":"11278559","id":"PMC_11278559","title":"Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278559","citation_count":389,"is_preprint":false},{"pmid":"17265492","id":"PMC_17265492","title":"Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.","date":"2007","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/17265492","citation_count":333,"is_preprint":false},{"pmid":"12568957","id":"PMC_12568957","title":"IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells.","date":"2003","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/12568957","citation_count":300,"is_preprint":false},{"pmid":"11956193","id":"PMC_11956193","title":"Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11956193","citation_count":241,"is_preprint":false},{"pmid":"17430884","id":"PMC_17430884","title":"Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17430884","citation_count":219,"is_preprint":false},{"pmid":"10751421","id":"PMC_10751421","title":"Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10751421","citation_count":197,"is_preprint":false},{"pmid":"14662755","id":"PMC_14662755","title":"Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14662755","citation_count":175,"is_preprint":false},{"pmid":"33116313","id":"PMC_33116313","title":"Exuberant fibroblast activity compromises lung function via ADAMTS4.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33116313","citation_count":166,"is_preprint":false},{"pmid":"10827174","id":"PMC_10827174","title":"The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10827174","citation_count":163,"is_preprint":false},{"pmid":"23602832","id":"PMC_23602832","title":"Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-κB.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23602832","citation_count":163,"is_preprint":false},{"pmid":"14701864","id":"PMC_14701864","title":"ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14701864","citation_count":156,"is_preprint":false},{"pmid":"18328163","id":"PMC_18328163","title":"The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review.","date":"2008","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/18328163","citation_count":155,"is_preprint":false},{"pmid":"11796708","id":"PMC_11796708","title":"Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11796708","citation_count":153,"is_preprint":false},{"pmid":"11741898","id":"PMC_11741898","title":"Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11741898","citation_count":153,"is_preprint":false},{"pmid":"10986281","id":"PMC_10986281","title":"Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10986281","citation_count":140,"is_preprint":false},{"pmid":"12202483","id":"PMC_12202483","title":"Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12202483","citation_count":123,"is_preprint":false},{"pmid":"12392761","id":"PMC_12392761","title":"Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).","date":"2002","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12392761","citation_count":119,"is_preprint":false},{"pmid":"18662930","id":"PMC_18662930","title":"Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18662930","citation_count":113,"is_preprint":false},{"pmid":"18042673","id":"PMC_18042673","title":"Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5.","date":"2007","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/18042673","citation_count":110,"is_preprint":false},{"pmid":"16003758","id":"PMC_16003758","title":"Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16003758","citation_count":106,"is_preprint":false},{"pmid":"17606262","id":"PMC_17606262","title":"ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques.","date":"2007","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/17606262","citation_count":100,"is_preprint":false},{"pmid":"17922681","id":"PMC_17922681","title":"Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage.","date":"2007","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/17922681","citation_count":98,"is_preprint":false},{"pmid":"14744861","id":"PMC_14744861","title":"Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14744861","citation_count":98,"is_preprint":false},{"pmid":"11284712","id":"PMC_11284712","title":"Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility.","date":"2001","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11284712","citation_count":94,"is_preprint":false},{"pmid":"23406982","id":"PMC_23406982","title":"MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23406982","citation_count":88,"is_preprint":false},{"pmid":"18941754","id":"PMC_18941754","title":"Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation.","date":"2008","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/18941754","citation_count":88,"is_preprint":false},{"pmid":"12646579","id":"PMC_12646579","title":"Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12646579","citation_count":88,"is_preprint":false},{"pmid":"16046392","id":"PMC_16046392","title":"Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16046392","citation_count":88,"is_preprint":false},{"pmid":"12528112","id":"PMC_12528112","title":"Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein.","date":"2003","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/12528112","citation_count":82,"is_preprint":false},{"pmid":"14561220","id":"PMC_14561220","title":"ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14561220","citation_count":79,"is_preprint":false},{"pmid":"22420304","id":"PMC_22420304","title":"The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22420304","citation_count":76,"is_preprint":false},{"pmid":"24474687","id":"PMC_24474687","title":"Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24474687","citation_count":76,"is_preprint":false},{"pmid":"23245439","id":"PMC_23245439","title":"ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections.","date":"2012","source":"The Annals of thoracic surgery","url":"https://pubmed.ncbi.nlm.nih.gov/23245439","citation_count":72,"is_preprint":false},{"pmid":"15780640","id":"PMC_15780640","title":"Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.","date":"2005","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/15780640","citation_count":70,"is_preprint":false},{"pmid":"28955046","id":"PMC_28955046","title":"Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28955046","citation_count":70,"is_preprint":false},{"pmid":"16771712","id":"PMC_16771712","title":"TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16771712","citation_count":70,"is_preprint":false},{"pmid":"11854269","id":"PMC_11854269","title":"ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11854269","citation_count":68,"is_preprint":false},{"pmid":"23082219","id":"PMC_23082219","title":"Regulated proteolytic processing of Reelin through interplay of tissue plasminogen activator (tPA), ADAMTS-4, ADAMTS-5, and their modulators.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23082219","citation_count":68,"is_preprint":false},{"pmid":"26288689","id":"PMC_26288689","title":"Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT).","date":"2015","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/26288689","citation_count":64,"is_preprint":false},{"pmid":"25045124","id":"PMC_25045124","title":"Leptin induces ADAMTS-4, ADAMTS-5, and ADAMTS-9 genes expression by mitogen-activated protein kinases and NF-ĸB signaling pathways in human chondrocytes.","date":"2014","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/25045124","citation_count":64,"is_preprint":false},{"pmid":"15161923","id":"PMC_15161923","title":"ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15161923","citation_count":59,"is_preprint":false},{"pmid":"20574651","id":"PMC_20574651","title":"ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20574651","citation_count":58,"is_preprint":false},{"pmid":"16289022","id":"PMC_16289022","title":"ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms.","date":"2005","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/16289022","citation_count":57,"is_preprint":false},{"pmid":"24126638","id":"PMC_24126638","title":"Tumor necrosis factor-α induces ADAMTS-4 expression in human osteoarthritis chondrocytes.","date":"2013","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24126638","citation_count":57,"is_preprint":false},{"pmid":"20645923","id":"PMC_20645923","title":"Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20645923","citation_count":56,"is_preprint":false},{"pmid":"17470431","id":"PMC_17470431","title":"TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17470431","citation_count":56,"is_preprint":false},{"pmid":"16677612","id":"PMC_16677612","title":"Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16677612","citation_count":52,"is_preprint":false},{"pmid":"27491335","id":"PMC_27491335","title":"Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27491335","citation_count":51,"is_preprint":false},{"pmid":"18387286","id":"PMC_18387286","title":"The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells.","date":"2008","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/18387286","citation_count":49,"is_preprint":false},{"pmid":"30426203","id":"PMC_30426203","title":"The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.","date":"2018","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/30426203","citation_count":49,"is_preprint":false},{"pmid":"30016600","id":"PMC_30016600","title":"Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30016600","citation_count":48,"is_preprint":false},{"pmid":"15457452","id":"PMC_15457452","title":"Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).","date":"2004","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15457452","citation_count":43,"is_preprint":false},{"pmid":"24732836","id":"PMC_24732836","title":"Upregulation of tumor necrosis factor α and ADAMTS-5, but not ADAMTS-4, in human intervertebral cartilage endplate with modic changes.","date":"2014","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/24732836","citation_count":42,"is_preprint":false},{"pmid":"25501175","id":"PMC_25501175","title":"Increased serum ADAMTS-4 in knee osteoarthritis: a potential indicator for the diagnosis of osteoarthritis in early stages.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25501175","citation_count":41,"is_preprint":false},{"pmid":"20662062","id":"PMC_20662062","title":"Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice.","date":"2010","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/20662062","citation_count":41,"is_preprint":false},{"pmid":"23438438","id":"PMC_23438438","title":"Mechanisms involved in suppression of ADAMTS4 expression in synoviocytes by high molecular weight hyaluronic acid.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23438438","citation_count":38,"is_preprint":false},{"pmid":"10961658","id":"PMC_10961658","title":"ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated rat astrocytes.","date":"2000","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/10961658","citation_count":38,"is_preprint":false},{"pmid":"27301579","id":"PMC_27301579","title":"Anti-inflammatory effects of ADAMTS-4 in a mouse model of ischemic stroke.","date":"2016","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/27301579","citation_count":37,"is_preprint":false},{"pmid":"34450332","id":"PMC_34450332","title":"Identification of novel ADAMTS1, ADAMTS4 and ADAMTS5 cleavage sites in versican using a label-free quantitative proteomics approach.","date":"2021","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/34450332","citation_count":36,"is_preprint":false},{"pmid":"23319426","id":"PMC_23319426","title":"ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice.","date":"2013","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23319426","citation_count":34,"is_preprint":false},{"pmid":"16741450","id":"PMC_16741450","title":"Expression of ADAMTS-4 (aggrecanase-1) and possible involvement in regression of lumbar disc herniation.","date":"2006","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/16741450","citation_count":34,"is_preprint":false},{"pmid":"22264287","id":"PMC_22264287","title":"Anti-angiogenic properties of ADAMTS-4 in vitro.","date":"2012","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22264287","citation_count":33,"is_preprint":false},{"pmid":"25709087","id":"PMC_25709087","title":"CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS-4 (Aggrecanase 1) Activity.","date":"2015","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25709087","citation_count":33,"is_preprint":false},{"pmid":"24595230","id":"PMC_24595230","title":"Pentosan polysulfate decreases myocardial expression of the extracellular matrix enzyme ADAMTS4 and improves cardiac function in vivo in rats subjected to pressure overload by aortic banding.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24595230","citation_count":33,"is_preprint":false},{"pmid":"32044329","id":"PMC_32044329","title":"Astrocyte-selective AAV-ADAMTS4 gene therapy combined with hindlimb rehabilitation promotes functional recovery after spinal cord injury.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32044329","citation_count":31,"is_preprint":false},{"pmid":"26495885","id":"PMC_26495885","title":"Association between ADAMTS-4 gene polymorphism and lumbar disc degeneration in Chinese Han population.","date":"2015","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/26495885","citation_count":31,"is_preprint":false},{"pmid":"22324945","id":"PMC_22324945","title":"Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.","date":"2011","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22324945","citation_count":31,"is_preprint":false},{"pmid":"20018883","id":"PMC_20018883","title":"Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20018883","citation_count":29,"is_preprint":false},{"pmid":"17487981","id":"PMC_17487981","title":"Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1).","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17487981","citation_count":29,"is_preprint":false},{"pmid":"19506088","id":"PMC_19506088","title":"Cell death-associated ADAMTS4 and versican degradation in vascular tissue.","date":"2009","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/19506088","citation_count":28,"is_preprint":false},{"pmid":"23778376","id":"PMC_23778376","title":"Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into a bovine intervertebral disc organ culture model.","date":"2013","source":"Spine","url":"https://pubmed.ncbi.nlm.nih.gov/23778376","citation_count":28,"is_preprint":false},{"pmid":"28099917","id":"PMC_28099917","title":"Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28099917","citation_count":28,"is_preprint":false},{"pmid":"18050214","id":"PMC_18050214","title":"Involvement of protein kinase Czeta in interleukin-1beta induction of ADAMTS-4 and type 2 nitric oxide synthase via NF-kappaB signaling in primary human osteoarthritic chondrocytes.","date":"2007","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/18050214","citation_count":28,"is_preprint":false},{"pmid":"32469162","id":"PMC_32469162","title":"MiR-126a-5p limits the formation of abdominal aortic aneurysm in mice and decreases ADAMTS-4 expression.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32469162","citation_count":27,"is_preprint":false},{"pmid":"20857147","id":"PMC_20857147","title":"Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation.","date":"2010","source":"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/20857147","citation_count":27,"is_preprint":false},{"pmid":"26809777","id":"PMC_26809777","title":"ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.","date":"2016","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/26809777","citation_count":26,"is_preprint":false},{"pmid":"29694979","id":"PMC_29694979","title":"Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29694979","citation_count":25,"is_preprint":false},{"pmid":"15262240","id":"PMC_15262240","title":"Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system.","date":"2004","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/15262240","citation_count":25,"is_preprint":false},{"pmid":"29153440","id":"PMC_29153440","title":"Relationship between ADAMTS4 and carotid atherosclerotic plaque vulnerability in humans.","date":"2017","source":"Journal of vascular surgery","url":"https://pubmed.ncbi.nlm.nih.gov/29153440","citation_count":24,"is_preprint":false},{"pmid":"26136925","id":"PMC_26136925","title":"Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.","date":"2015","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26136925","citation_count":24,"is_preprint":false},{"pmid":"24752352","id":"PMC_24752352","title":"IL-6 upregulates a disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS-2) in human osteosarcoma cells mediated by JNK pathway.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24752352","citation_count":24,"is_preprint":false},{"pmid":"33350314","id":"PMC_33350314","title":"Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty.","date":"2020","source":"Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/33350314","citation_count":23,"is_preprint":false},{"pmid":"11254106","id":"PMC_11254106","title":"Characterization of 5'-flanking region of human aggrecanase-1 (ADAMTS4) gene.","date":"2000","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/11254106","citation_count":22,"is_preprint":false},{"pmid":"18671975","id":"PMC_18671975","title":"Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18671975","citation_count":22,"is_preprint":false},{"pmid":"22205175","id":"PMC_22205175","title":"Expression of ADAMTS-2, -3, -13, and -14 in culprit coronary lesions in patients with acute myocardial infarction or stable angina.","date":"2012","source":"Journal of thrombosis and thrombolysis","url":"https://pubmed.ncbi.nlm.nih.gov/22205175","citation_count":22,"is_preprint":false},{"pmid":"27082728","id":"PMC_27082728","title":"Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27082728","citation_count":21,"is_preprint":false},{"pmid":"16427204","id":"PMC_16427204","title":"Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13.","date":"2005","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/16427204","citation_count":21,"is_preprint":false},{"pmid":"27844209","id":"PMC_27844209","title":"The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.","date":"2016","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/27844209","citation_count":20,"is_preprint":false},{"pmid":"29236314","id":"PMC_29236314","title":"IL-1β-induced miR-34a up-regulation inhibits Cyr61 to modulate osteoarthritis chondrocyte proliferation through ADAMTS-4.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29236314","citation_count":20,"is_preprint":false},{"pmid":"16945513","id":"PMC_16945513","title":"Effects of covalently attached chondroitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13.","date":"2006","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16945513","citation_count":20,"is_preprint":false},{"pmid":"21584905","id":"PMC_21584905","title":"Partially redundant functions of Adamts1 and Adamts4 in the perinatal development of the renal medulla.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21584905","citation_count":19,"is_preprint":false},{"pmid":"16723216","id":"PMC_16723216","title":"An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients.","date":"2006","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16723216","citation_count":19,"is_preprint":false},{"pmid":"22735305","id":"PMC_22735305","title":"Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22735305","citation_count":19,"is_preprint":false},{"pmid":"36403758","id":"PMC_36403758","title":"Glucose-stimulated PGC-1α couples with CBP and Runx2 to mediate intervertebral disc degeneration through transactivation of ADAMTS4/5 in diet-induced obesity mice.","date":"2022","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/36403758","citation_count":18,"is_preprint":false},{"pmid":"19342688","id":"PMC_19342688","title":"Adaptor proteins and Ras synergistically regulate IL-1-induced ADAMTS-4 expression in human chondrocytes.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19342688","citation_count":18,"is_preprint":false},{"pmid":"34718343","id":"PMC_34718343","title":"Synergistic upregulation of ADAMTS4 (aggrecanase-1) by cytokines and its suppression in knee osteoarthritic synovial fibroblasts.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34718343","citation_count":17,"is_preprint":false},{"pmid":"33300067","id":"PMC_33300067","title":"Inflammasome components and ADAMTS4 in premature rupture of membranes.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33300067","citation_count":17,"is_preprint":false},{"pmid":"28207788","id":"PMC_28207788","title":"Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: A new therapeutic approach for intervertebral disc disorders.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28207788","citation_count":17,"is_preprint":false},{"pmid":"20625753","id":"PMC_20625753","title":"Elevated level of ADAMTS4 in plasma and peripheral monocytes from patients with acute coronary syndrome.","date":"2010","source":"Clinical research in cardiology : official journal of the German Cardiac Society","url":"https://pubmed.ncbi.nlm.nih.gov/20625753","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56289,"output_tokens":7559,"usd":0.141126},"stage2":{"model":"claude-opus-4-6","input_tokens":11363,"output_tokens":4426,"usd":0.251198},"total_usd":0.392324,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"ADAMTS-4 cleaves aggrecan at the Glu373-Ala374 bond (IGD) and at four additional sites within the chondroitin sulfate-rich region (Glu1480-Gly1481, Glu1667-Gly1668, Glu1771-Ala1772, Glu1871-Leu1872), with CS-rich region cleavage being more efficient than IGD cleavage.\",\n      \"method\": \"In vitro cleavage assay with recombinant human ADAMTS-4 and native aggrecan; N-terminal sequencing of fragments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assay with N-terminal sequencing, site-specific identification\",\n      \"pmids\": [\"10751421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The thrombospondin type-1 (TSP-1) motif of ADAMTS-4 binds to glycosaminoglycans of aggrecan and is required for substrate recognition and cleavage; truncation lacking TSP-1 abolishes aggrecanase activity, and GAG-free aggrecan is not cleaved.\",\n      \"method\": \"Truncation mutant activity assays, peptide competition binding assays, cleavage assays with GAG-free aggrecan\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (truncation mutants, peptide competition, substrate modification) in a single study\",\n      \"pmids\": [\"10827174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ADAMTS-4 cleaves brevican at the Glu395-Ser396 bond within the central non-homologous domain, a site distinct from the Ala360-Phe361 bond cleaved by MMPs.\",\n      \"method\": \"In vitro cleavage assay with recombinant ADAMTS-4 and brevican; NH2-terminal sequence analysis of fragments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with N-terminal sequencing confirming cleavage site\",\n      \"pmids\": [\"10986281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TIMP-3 N-terminal inhibitory domain is a potent inhibitor of ADAMTS-4 with Ki values in the subnanomolar range, making it the first identified endogenous inhibitor of aggrecanases.\",\n      \"method\": \"In vitro inhibition assay using truncated N-TIMP-3 expressed in bacteria against recombinant ADAMTS-4 and ADAMTS-5\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro inhibition kinetics with purified recombinant proteins\",\n      \"pmids\": [\"11278243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ADAMTS-4 cleaves versican V1 at the Glu441-Ala442 bond, generating a DPEAAE neoepitope, and mature ADAMTS-4 was detected in human aortic intima.\",\n      \"method\": \"In vitro cleavage of recombinant versican substrate and native human versican; neoepitope antiserum detection; Western analysis of aortic extracts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assay with site identification and in vivo correlation\",\n      \"pmids\": [\"11278559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ADAMTS-4 activation requires two sequential steps: (1) prodomain removal by a furin-like activity generating the p75 form, and (2) MMP-mediated C-terminal truncation generating p60/p50 forms; only the C-terminally truncated forms exhibit aggrecanase activity.\",\n      \"method\": \"Stable transfection of human chondrosarcoma cells; Western analysis with domain-specific antisera; furin and MMP inhibitor treatments; preparative SDS-PAGE isolation and activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple inhibitor approaches with direct activity assays on isolated forms\",\n      \"pmids\": [\"11796708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Full-length ADAMTS-4 undergoes autocatalytic C-terminal truncation to generate ~53 kDa and ~40 kDa isoforms with reduced affinity for sulfated GAGs; multiple GAG-binding sites are present in the cysteine-rich and spacer domains in addition to the TSP-1 motif.\",\n      \"method\": \"C-terminal sequencing and mass analysis of autocleaved products; binding competition with native and deglycosylated aggrecan; synthetic peptide competition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical characterization with multiple orthogonal approaches\",\n      \"pmids\": [\"12202483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ADAMTS-4 cleaves at the Glu373-Ala374 aggrecanase site primarily, and secondarily cleaves at the Asn341-Phe342 MMP site; TIMP-3 (but not TIMP-1 or TIMP-2) inhibits both cleavages, confirming they are genuine ADAMTS-4 activities.\",\n      \"method\": \"In vitro cleavage of native and recombinant aggrecan; inhibitor studies with TIMP-3, TIMP-1, TIMP-2; cleavage site mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-directed mutagenesis of cleavage sites combined with selective TIMP inhibition\",\n      \"pmids\": [\"11854269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The non-catalytic C-terminal spacer domain of ADAMTS-4 masks general proteolytic activity; deletion of the spacer domain broadens substrate specificity (enabling cleavage of Glu373-Ala374, Cm-Tf, fibromodulin, decorin), while the thrombospondin type I domain is critical for aggrecanase activity; full-length ADAMTS-4 binds pericellular/extracellular matrix via its spacer domain.\",\n      \"method\": \"Domain deletion mutant expression in mammalian cells; aggrecan-degrading and general proteolytic activity assays; matrix binding studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic domain deletion mutagenesis with multiple substrate assays\",\n      \"pmids\": [\"14662755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"IL-1 induces aggrecanase activity in chondrocytes by activating a constitutively produced pool of ADAMTS-4 (not by increasing protein abundance); IL-1-mediated activation involves an activator that can be blocked by heparin or chondroitinase ABC treatment.\",\n      \"method\": \"Western blot of cell lysates and cartilage; immunofluorescence; aggrecanase activity assay on peptide substrate; heparin and chondroitinase treatment\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods in single lab study\",\n      \"pmids\": [\"12528112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ADAMTS-4 activation on the cell surface involves C-terminal cleavage of the p68 form to the p53 form mediated by GPI-anchored MT4-MMP (MMP-17); the activated p53 form associates with syndecan-1 through both chondroitin sulfate and heparan sulfate chains.\",\n      \"method\": \"Co-transfection with active/inactive MT4-MMP mutants; phosphatidylinositol-specific phospholipase C treatment; glycosaminoglycan lyase digestions; fluorescence-assisted carbohydrate electrophoresis; immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal approaches including active-site mutant controls and specific glycosaminoglycan characterization\",\n      \"pmids\": [\"14701864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Furin cleaves pro-ADAMTS-4 at RPRR/RAKR/KR sites in the trans-Golgi network to remove the prodomain; pro-ADAMTS-4 co-precipitates with furin (but mature form does not), indicating physical interaction of furin with the prodomain.\",\n      \"method\": \"Furin-specific inhibitor treatment; RNA interference of furin; brefeldin A treatment; co-localization by immunofluorescence; co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple approaches including RNAi, inhibitors, co-IP, and subcellular localization\",\n      \"pmids\": [\"14744861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ADAMTS-4 binds to the C-terminal domain of fibronectin via its spacer domain; this interaction inhibits aggrecanase activity with IC50 of ~110 nM; ADAMTS-4 co-localizes with fibronectin on the cell surface.\",\n      \"method\": \"Yeast two-hybrid screening; chemical cross-linking; solid-phase binding assay; confocal microscopy; aggrecanase activity inhibition assay with fibronectin and fragments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — yeast two-hybrid plus multiple biochemical validations plus functional inhibition assay\",\n      \"pmids\": [\"15161923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ADAMTS-4 cleaves brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein (GHAP); multiple ADAMTS-4 protein forms are present in human cerebellum extracts.\",\n      \"method\": \"Neoepitope antiserum identification; in vitro digestion of human cerebellum proteoglycans with ADAMTS-4; Western analysis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic cleavage with neoepitope identification\",\n      \"pmids\": [\"14561220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"N-terminal activation of ADAMTS-4 is mediated by proprotein convertases furin, PACE4, and PC5/6 (cleaving at Arg212/Phe213), and also by MMP-9 and trypsin; autocatalytic prodomain removal does not occur under standard conditions but can occur at basic pH (8-10).\",\n      \"method\": \"In vitro activation assays with various proteinases across pH ranges, ionic strengths, and temperatures; prodomain removal and activity measurement\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive in vitro reconstitution with multiple conditions\",\n      \"pmids\": [\"16289022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TIMP-3 inhibition of full-length ADAMTS-4 is enhanced in the presence of aggrecan through binding of chondroitin 6-sulfate glycosaminoglycans to the TSP-1 and spacer domains of ADAMTS-4, forming a complex with improved TIMP-3 binding affinity.\",\n      \"method\": \"FRET peptide assay; binding competition experiments with native and deglycosylated aggrecan; specific glycosaminoglycan competition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative kinetic assay plus substrate competition experiments\",\n      \"pmids\": [\"17470431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Non-catalytic ancillary domains of ADAMTS-4 regulate extracellular matrix localization (spacer domain is critical) and proteolytic activity; the spacer domain is required for matrix retention, while sequential inclusion of C-terminal domains enhances activity against multiple substrates.\",\n      \"method\": \"Domain deletion mutant expression; ECM interaction studies; activity assays against aggrecan, Cm-Tf, fibromodulin, decorin, biglycan, fibronectin\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic domain deletion with multiple substrate assays, comparative with ADAMTS-5\",\n      \"pmids\": [\"17430884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structures of ADAMTS-4 (in apo and inhibitor-bound forms) reveal two catalytic-site configurations: an autoinhibited closed form and an open binding form, suggesting the enzyme exists as an ensemble of isomers with only the open form being proteolytically active.\",\n      \"method\": \"X-ray crystallography of human ADAMTS-4 in apo and inhibitor-bound forms\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with structural functional interpretation\",\n      \"pmids\": [\"18042673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ADAMTS-4 aggrecan cleavage operates through an exosite mechanism: substrate initially binds at an exosite (reflected by apparent Km), followed by active-site binding; active-site inhibitors show noncompetitive kinetics with aggrecan but competitive kinetics with peptide substrates, consistent with this two-step model.\",\n      \"method\": \"Inhibition kinetics with hydroxamic acid SC81956 using varying aggrecan and peptide substrate concentrations; fluorogenic peptide assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous kinetic analysis with multiple substrate types revealing mechanistic model\",\n      \"pmids\": [\"17487981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ADAMTS-4 cleaves hevin (SPARC-like 1) in the mouse cerebellum; this proteolysis is important for normal cerebellar development; ADAMTS-4 co-localizes with hevin-derived SPARC-like fragments in vivo.\",\n      \"method\": \"In vitro digestion of hevin by ADAMTS-4; comparison of brain lysate fragments with in vitro cleavage products; co-localization by monoclonal antibody; developmental analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro cleavage corroborated by in vivo co-localization\",\n      \"pmids\": [\"20018883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"N-TIMP-3 reactive-site mutants with additional N-terminal alanine residues selectively inhibit ADAMTS-4 and ADAMTS-5 over MMPs; these mutants inhibit aggrecan but not collagen degradation in cartilage explants; molecular modelling indicates unique stabilizing contacts with the catalytic domains.\",\n      \"method\": \"In vitro inhibition assays with recombinant proteins; cartilage explant aggrecan/collagen degradation assays; molecular modelling\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — recombinant protein inhibition kinetics combined with tissue-level functional validation\",\n      \"pmids\": [\"20645923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ADAMTS-4 is endocytosed via LRP1 on chondrocyte cell surface; the cysteine-rich and spacer domains mediate LRP1 binding; ADAMTS-4 binds LRP1 clusters II and IV with KD ~98 and 73 nM respectively; half-life of endocytosis ~220 min; ADAMTS-5 competitively inhibits ADAMTS-4 endocytosis due to higher LRP1 affinity.\",\n      \"method\": \"Domain deletion mutagenesis; soluble LRP1 ligand binding cluster binding assays; endocytosis rate measurements; competitive inhibition experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative binding measurements with domain mapping and competitive inhibition\",\n      \"pmids\": [\"24474687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ADAMTS-4 degrades chondroitin sulfate proteoglycan core proteins (brevican, neurocan, phosphacan) and reverses their inhibition of neurite outgrowth in vitro; local administration of ADAMTS-4 promotes motor function recovery and axonal regeneration/sprouting after spinal cord contusion injury in mice.\",\n      \"method\": \"In vitro proteoglycan cleavage assay; in vitro neurite growth assay; in vivo spinal cord contusion model with local ADAMTS-4 administration; motor function assessment\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro enzyme activity correlated with in vivo functional recovery\",\n      \"pmids\": [\"22420304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TNF-α and IL-1β regulate ADAMTS-4 expression in nucleus pulposus cells through MAPK (ERK1, p38α, p38β2, p38γ) and NF-κB (p65, IKK-α, IKK-β) signaling; p65 activates the ADAMTS4 promoter while p50 blocks this; lentiviral shRNA knockdown of pathway components reduces ADAMTS-4 and aggrecan degradation.\",\n      \"method\": \"Real-time RT-PCR; Western blotting; transient transfections with promoter constructs; gain/loss-of-function with dominant negative constructs; lentiviral shRNA knockdown; MAPK/NF-κB inhibitor studies\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including promoter assays, genetic knockdown, and pharmacological inhibition\",\n      \"pmids\": [\"23602832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCN1 (Cyr61) binds specifically to the cysteine-rich domain of ADAMTS-4 and inhibits its aggrecanase activity; TGF-β upregulates CCN1 which suppresses ADAMTS-4 activity even when ADAMTS-4 protein is induced, while IL-1α downregulates CCN1 allowing ADAMTS-4 activity.\",\n      \"method\": \"Co-purification and mass spectrometry identification; immunoprecipitation; solid-phase binding assay; aggrecan digestion assay; domain deletion mapping; siRNA knockdown of CCN1\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — proteomics-based identification followed by multiple biochemical validations and functional inhibition assay\",\n      \"pmids\": [\"25709087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ADAMTS-4 translocates to the nucleus in smooth muscle cells under stress conditions and directly cleaves/degrades poly ADP ribose polymerase-1 (PARP-1), leading to SMC apoptosis; ADAMTS-4 deficiency reduces aortic aneurysm formation, versican degradation, and macrophage infiltration in mice.\",\n      \"method\": \"Mouse knockout model (Adamts4-/-); immunofluorescence for nuclear translocation; in vitro PARP-1 cleavage assay; aortic diameter measurement; histological analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro PARP-1 cleavage assay plus in vivo knockout with multiple phenotypic readouts\",\n      \"pmids\": [\"28955046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ADAMTS-4 generates N-truncated Aβ4-x peptides by cleaving at a recognition site within the amyloid-β sequence; inducible overexpression increases Aβ4-40 secretion without altering Aβ1-x levels; ADAMTS4 knockout reduces Aβ4-40 levels in 5xFAD mice; ADAMTS-4 is exclusively expressed in oligodendrocytes in adult mouse brain.\",\n      \"method\": \"Inducible HEK293 overexpression; ADAMTS4 knockout mouse on 5xFAD background; cultured oligodendrocytes from ADAMTS4-/- mice; Aβ peptide measurement by ELISA/immunoassay\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — overexpression and knockout approaches with direct substrate cleavage measurement\",\n      \"pmids\": [\"30426203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ADAMTS-4 produced by damage-responsive lung fibroblasts remodels the ECM during viral infection, promoting robust immune cell infiltration; ADAMTS-4 levels in the lower respiratory tract correlate with severity of influenza infection in humans.\",\n      \"method\": \"Mouse influenza model; single-cell transcriptomics identifying fibroblast activation states; ADAMTS4 functional studies in lung; human cohort ADAMTS4 measurements\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell transcriptomics with in vivo functional evidence and human clinical correlation\",\n      \"pmids\": [\"33116313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ADAMTS-4 cleaves versican V1 at multiple sites beyond the known Glu441-Ala442 bond, with a preference for P1-Glu residues; 21 novel cleavage sites were identified within versican.\",\n      \"method\": \"Label-free quantitative LC-MS/MS proteomics comparing active vs. catalytically inactive mutant ADAMTS-4 digests of recombinant versican; z-score statistical ranking\",\n      \"journal\": \"Journal of proteomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative proteomics with catalytically inactive mutant controls\",\n      \"pmids\": [\"34450332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The human ADAMTS-4 promoter is regulated by transcription factors NFATp and Runx2 (binding sites identified); the NFI site at -441 to -429 acts as a negative regulator in chondrocytes; the region -383 to +10 is required for full promoter activity.\",\n      \"method\": \"Promoter cloning; deletion variants reporter assays; transfection in porcine chondrocytes and NIH3T3 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays with deletion mutants in relevant cell types\",\n      \"pmids\": [\"16677612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sox4 transcription factor directly binds the ADAMTS-4 promoter and upregulates its expression; Sox4 overexpression induces ADAMTS-4 and ADAMTS-5 expression and causes articular cartilage destruction in organ cultures.\",\n      \"method\": \"Microarray; luciferase reporter assay; chromatin immunoprecipitation; adenovirus-mediated Sox4 overexpression in mouse femoral head cartilage organ cultures\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP plus reporter assay plus in vivo organ culture functional validation\",\n      \"pmids\": [\"30016600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Hyaluronan (HA) suppresses IL-1α-induced ADAMTS-4 expression in osteoarthritic chondrocytes through CD44 and ICAM1 signaling pathways, by downregulating IRAK-1 and ERK1/2 phosphorylation via IRAK-M upregulation; HA does not directly inhibit ADAMTS-4 enzymatic activity.\",\n      \"method\": \"Real-time PCR; Western blotting; immunoblotting for signaling molecules; antibody blocking of CD44/ICAM1; siRNA knockdown of ADAMTS-4\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical approaches identifying signaling intermediates\",\n      \"pmids\": [\"18662930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ADAMTS-4 and ADAMTS-5 cleave Reelin, with regulation by tPA, TIMPs, α-2-macroglobulin, serpins, and MMP-9; their expression overlaps with Reelin in the murine hippocampus.\",\n      \"method\": \"In vitro cleavage assays; inhibitor co-incubation studies; immunofluorescence co-localization in brain\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro cleavage assay with multiple endogenous modulators tested\",\n      \"pmids\": [\"23082219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ADAMTS-4 and ADAMTS-1 play redundant and essential roles in perinatal renal medulla development; combined knockout of both leads to lethal renal medulla thinning in >95% of double-null mice, while single knockouts are phenotypically normal.\",\n      \"method\": \"Gene targeting to create Adamts4-null mice; crossing with Adamts1-null mice; histological analysis of kidneys\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-knockout genetic epistasis with clear developmental phenotype\",\n      \"pmids\": [\"21584905\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADAMTS-4 is a secreted zinc metalloproteinase activated by furin-mediated prodomain removal in the trans-Golgi network and subsequent MMP/MT4-MMP-mediated C-terminal spacer domain truncation at the cell surface; it cleaves aggrecan, versican, brevican, and other proteoglycans at Glu-X bonds via an exosite-assisted mechanism requiring GAG binding through its TSP-1, cysteine-rich, and spacer domains; its activity is regulated extracellularly by TIMP-3 (Ki subnanomolar), fibronectin, and CCN1 binding, and its clearance is controlled by LRP1-mediated endocytosis; it also generates N-truncated Aβ4-x amyloid peptides and can translocate to the nucleus to cleave PARP-1 in smooth muscle cells, driving apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ADAMTS4 encodes a secreted zinc metalloproteinase that functions as a major aggrecanase and broad-spectrum proteoglycan-degrading enzyme, cleaving aggrecan, versican, brevican, neurocan, phosphacan, hevin, and Reelin at Glu-X bonds through an exosite-assisted mechanism requiring glycosaminoglycan recognition by its thrombospondin type-1, cysteine-rich, and spacer domains [PMID:10751421, PMID:10827174, PMID:17487981, PMID:22420304]. The enzyme is activated by sequential prodomain removal via furin/PACE4/PC5-6 in the trans-Golgi network followed by C-terminal spacer domain truncation by MT4-MMP or other MMPs at the cell surface, generating active p60/p53 forms with altered substrate specificity and reduced matrix retention [PMID:11796708, PMID:14744861, PMID:14701864, PMID:14662755]. Its activity is regulated extracellularly by TIMP-3 (subnanomolar Ki, enhanced by aggrecan-derived chondroitin sulfate), fibronectin binding to the spacer domain, CCN1 binding to the cysteine-rich domain, and LRP1-mediated endocytic clearance, while transcription is controlled by NF-κB/MAPK signaling downstream of IL-1β/TNF-α and by transcription factors Sox4, NFATp, and Runx2 [PMID:11278243, PMID:17470431, PMID:15161923, PMID:25709087, PMID:24474687, PMID:23602832, PMID:30016600]. Beyond cartilage proteoglycan catabolism, ADAMTS-4 generates N-truncated Aβ4-x amyloid peptides in oligodendrocytes, translocates to the nucleus to cleave PARP-1 and drive smooth muscle cell apoptosis during aortic aneurysm, promotes axonal regeneration by degrading inhibitory CSPGs after spinal cord injury, and remodels lung ECM during viral infection [PMID:30426203, PMID:28955046, PMID:22420304, PMID:33116313].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing ADAMTS-4 as a multi-site aggrecanase and identifying its proteoglycan substrate repertoire resolved the identity of the long-sought 'aggrecanase' activity and revealed that it also cleaves brevican at a distinct site from MMPs.\",\n      \"evidence\": \"In vitro cleavage of native aggrecan and brevican with recombinant ADAMTS-4, N-terminal sequencing of fragments\",\n      \"pmids\": [\"10751421\", \"10986281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each cleavage site to in vivo cartilage degradation unknown\", \"Kinetic parameters for individual sites not fully determined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that the TSP-1 motif binds aggrecan GAGs and is essential for cleavage established the principle that ADAMTS-4 uses non-catalytic domains for substrate recognition, not just catalysis.\",\n      \"evidence\": \"Truncation mutants, peptide competition, and GAG-free aggrecan cleavage assays\",\n      \"pmids\": [\"10827174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise structural basis of TSP-1–GAG interaction not resolved\", \"Whether TSP-1 domain is equally required for non-aggrecan substrates unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying TIMP-3 as the first endogenous inhibitor of ADAMTS-4 with subnanomolar affinity, and showing versican cleavage and aortic presence, defined the enzyme's regulatory framework and expanded its role beyond cartilage.\",\n      \"evidence\": \"Quantitative in vitro inhibition kinetics; in vitro versican V1 cleavage with neoepitope detection; Western blot of human aortic extracts\",\n      \"pmids\": [\"11278243\", \"11278559\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of TIMP-3 regulation in specific tissues not demonstrated\", \"Other potential endogenous inhibitors not yet screened\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovering that ADAMTS-4 activation requires sequential furin-mediated prodomain removal and MMP-mediated C-terminal truncation revealed a two-step zymogen activation pathway controlling enzyme specificity.\",\n      \"evidence\": \"Stable transfection with domain-specific antisera, furin/MMP inhibitor treatments, and activity assays of isolated enzyme forms; autocatalysis characterization with mass analysis\",\n      \"pmids\": [\"11796708\", \"12202483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the specific MMP(s) responsible in vivo not definitively established at this stage\", \"Relative rates of autocatalysis versus MMP-mediated truncation in physiological settings unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying MT4-MMP as the cell-surface protease generating the active p53 form and syndecan-1 as a cell-surface docking partner placed ADAMTS-4 activation in a pericellular context, while IL-1 was shown to activate a pre-existing enzyme pool rather than inducing new synthesis.\",\n      \"evidence\": \"Co-transfection with MT4-MMP mutants, GAG lyase digestions, immunoprecipitation; chondrocyte IL-1 stimulation with heparin/chondroitinase treatment\",\n      \"pmids\": [\"14701864\", \"12528112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether syndecan-1 association enhances or restricts activity in vivo unknown\", \"Nature of the GAG-sensitive IL-1-induced activator not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Systematic domain deletion showed that the spacer domain both masks broad proteolytic activity and anchors the enzyme in ECM, revealing a built-in autoinhibitory/localization mechanism.\",\n      \"evidence\": \"Domain deletion mutants with multiple substrate and matrix binding assays\",\n      \"pmids\": [\"14662755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of spacer-mediated autoinhibition not resolved\", \"How spacer removal alters substrate selectivity in vivo unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapping furin cleavage to the trans-Golgi network via physical furin–prodomain interaction and identifying fibronectin as an extracellular inhibitor binding the spacer domain defined two distinct compartmental control points for ADAMTS-4 activity.\",\n      \"evidence\": \"Furin RNAi, brefeldin A treatment, co-IP; yeast two-hybrid, cross-linking, and activity inhibition with fibronectin\",\n      \"pmids\": [\"14744861\", \"15161923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether fibronectin inhibition is relevant in cartilage ECM context not tested\", \"Contribution of PACE4/PC5-6 versus furin in different tissues not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Crystal structures revealing open/closed catalytic-site conformations and kinetic demonstration of an exosite mechanism unified the biochemical observations into a model where substrate first docks at an exosite before engaging the active site.\",\n      \"evidence\": \"X-ray crystallography of apo and inhibitor-bound forms; inhibition kinetics showing noncompetitive behavior with aggrecan versus competitive with peptides\",\n      \"pmids\": [\"18042673\", \"17487981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal with a macromolecular substrate to identify the exosite structurally\", \"Whether the open/closed equilibrium is modulated by cofactors in vivo unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing that TIMP-3 inhibition is enhanced by aggrecan-derived chondroitin 6-sulfate binding to the ancillary domains revealed a substrate-assisted inhibition mechanism, linking GAG binding to regulation.\",\n      \"evidence\": \"FRET kinetic assays with native and deglycosylated aggrecan; specific GAG competition\",\n      \"pmids\": [\"17470431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this applies to other substrates or tissue contexts not established\", \"Stoichiometry of the ternary TIMP-3/ADAMTS-4/CS complex not determined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery of hevin as a brain substrate and ADAMTS-4's role in cerebellar development expanded its functional scope beyond connective tissue proteoglycan degradation.\",\n      \"evidence\": \"In vitro hevin cleavage, co-localization of ADAMTS-4 with hevin-derived fragments in mouse cerebellum\",\n      \"pmids\": [\"20018883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Hevin cleavage site not precisely mapped\", \"No knockout validation of this function in cerebellum\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Double knockout with ADAMTS-1 revealed redundant essential roles in renal medulla morphogenesis, establishing ADAMTS-4 as a developmental enzyme with tissue-specific requirements masked by paralog compensation.\",\n      \"evidence\": \"Adamts4−/−;Adamts1−/− double-knockout mice with lethal renal medulla thinning\",\n      \"pmids\": [\"21584905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific substrate(s) mediating renal development not identified\", \"Whether versican is the relevant renal substrate unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating LRP1-mediated endocytosis via the cysteine-rich/spacer domains and competitive displacement by ADAMTS-5 defined the clearance pathway controlling extracellular ADAMTS-4 levels.\",\n      \"evidence\": \"Domain deletion binding assays, endocytosis rate measurements, competitive inhibition with ADAMTS-5\",\n      \"pmids\": [\"24474687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation of LRP1 clearance pathway not performed\", \"Whether LRP1 endocytosis delivers ADAMTS-4 for degradation or recycling unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapping the signaling cascades (MAPK/NF-κB) through which TNF-α and IL-1β induce ADAMTS4 transcription, along with identification of promoter-binding transcription factors (NFATp, Runx2, Sox4), defined the transcriptional regulation of the gene in chondrocytes and intervertebral disc cells.\",\n      \"evidence\": \"Promoter reporter assays, ChIP, lentiviral shRNA knockdown of pathway components, MAPK/NF-κB inhibitors; adenoviral Sox4 overexpression in organ cultures\",\n      \"pmids\": [\"23602832\", \"16677612\", \"30016600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Epigenetic regulation not addressed\", \"Whether these pathways operate identically in cartilage versus vascular tissue unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of CCN1 as a TGF-β-induced extracellular inhibitor binding the cysteine-rich domain added a third mode of extracellular activity control alongside TIMP-3 and fibronectin.\",\n      \"evidence\": \"Co-purification/MS identification, immunoprecipitation, domain mapping, siRNA knockdown, aggrecan digestion assay\",\n      \"pmids\": [\"25709087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CCN1, fibronectin, and TIMP-3 compete or cooperate in vivo not tested\", \"Structural basis of CCN1 inhibition unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovering nuclear translocation and PARP-1 cleavage in stressed smooth muscle cells, along with knockout protection from aortic aneurysm, revealed an unexpected intracellular pro-apoptotic function beyond its canonical extracellular role.\",\n      \"evidence\": \"Adamts4−/− mouse aortic aneurysm model; immunofluorescence for nuclear localization; in vitro PARP-1 cleavage assay\",\n      \"pmids\": [\"28955046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of nuclear import not identified\", \"Whether PARP-1 cleavage is direct in vivo or requires cofactors unknown\", \"Generalizability of nuclear function beyond SMCs not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that ADAMTS-4 generates Aβ4-x amyloid peptides in oligodendrocytes and that knockout reduces Aβ4-40 in an Alzheimer's model established the enzyme as a novel amyloid-processing protease.\",\n      \"evidence\": \"Inducible HEK293 overexpression; ADAMTS4 knockout on 5xFAD background; cultured oligodendrocytes; Aβ peptide ELISA\",\n      \"pmids\": [\"30426203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise cleavage site within APP/Aβ sequence not mapped at single-residue resolution\", \"Contribution to human AD pathology not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Implicating fibroblast-derived ADAMTS-4 in lung ECM remodeling during viral infection, with clinical correlation to influenza severity, extended the enzyme's pathophysiological role to innate immunity.\",\n      \"evidence\": \"Mouse influenza model with single-cell transcriptomics; human cohort ADAMTS4 measurements\",\n      \"pmids\": [\"33116313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific lung ECM substrates cleaved during infection not identified\", \"Whether ADAMTS-4 is protective or pathogenic in this context not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Comprehensive proteomics identified 21 novel cleavage sites in versican V1 confirming broad P1-Glu preference, refining the substrate recognition model.\",\n      \"evidence\": \"Label-free quantitative LC-MS/MS with catalytically inactive mutant controls\",\n      \"pmids\": [\"34450332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of individual cleavage sites in vivo unknown\", \"Whether these sites are cleaved in native tissue-associated versican not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of exosite-mediated substrate recognition on full-length enzyme, the mechanism of nuclear translocation, the pathophysiological relevance of Aβ4-x generation to Alzheimer's disease, and the specific substrates mediating ADAMTS-4's developmental roles in kidney and cerebellum.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No co-crystal structure with macromolecular substrate\", \"Nuclear import mechanism uncharacterized\", \"In vivo contribution to AD amyloid burden in humans unknown\", \"Developmental substrates in kidney and brain not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4, 7, 8, 13, 19, 22, 25, 26, 28, 32]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2, 4, 8, 22, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 6, 8, 12, 16, 27]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [8, 12, 16]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [10, 12]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [0, 4, 8, 16, 22, 27, 28]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [5, 11, 14]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [22, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TIMP3\",\n      \"LRP1\",\n      \"FN1\",\n      \"CCN1\",\n      \"FURIN\",\n      \"MMP17\",\n      \"SDC1\",\n      \"PARP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}